Equities

Shield Therapeutics PLC

STX:LSE

Shield Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1.75
  • Today's Change-0.10 / -5.41%
  • Shares traded3.82m
  • 1 Year change-74.07%
  • Beta1.5726
Data delayed at least 20 minutes, as of May 17 2024 16:27 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2022202220212020
ASSETS
Cash And Short Term Investments3.40122.94
Total Receivables, Net7.011.770.66
Total Inventory1.761.641.38
Prepaid expenses--1.730.26
Other current assets, total------
Total current assets12175.23
Property, plant & equipment, net0.240.300.03
Goodwill, net------
Intangibles, net142727
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets274433
LIABILITIES
Accounts payable--1.310.40
Accrued expenses--2.191.75
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.110.160.03
Other current liabilities, total1.280.060.08
Total current liabilities133.722.25
Total long term debt7.2500
Total debt7.350.160.03
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities203.722.25
SHAREHOLDERS EQUITY
Common stock5.373.241.76
Additional paid-in capital14911588
Retained earnings (accumulated deficit)(158)(79)(60)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total9.611.450.05
Total equity6.554130
Total liabilities & shareholders' equity274433
Total common shares outstanding267222128
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.